SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre-close Trading Statement

26 Jul 2011 07:00

RNS Number : 0254L
James Halstead PLC
26 July 2011
 



 

 

26 July 2011

 

James Halstead plc

 

Pre-close Trading Statement

 

"Continues robust trading and confident of reporting record profit"

 

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update prior to entering the close period ahead of its results for the year to 30 June 2011.

 

In its interim results statement issued on 31 March 2011, the Company stated that: "The first half year trading was very solid with record revenue representing an increase of 15.2%. The Chairman, Mr. Geoffrey Halstead expressed confidence that the Company would forge ahead in the second half year.

 

Overall, this confidence was well founded and the Company has continued to trade robustly. Trading performances across the Company's export markets have remained strong and overall turnover should have increased by around 15%. The growth in our export markets is particularly strong and it is too simplistic to put this down to the value of sterling. Our exports have grown over a generation and we are well placed to continue supplying flooring to major infrastructure projects across the globe.

 

In the UK the commercial flooring market place has declined as might be expected in a building recession. Notwithstanding this, we expect turnover in the UK to be ahead of last year. Our home market has faced the challenges of price competition (as manufacturers look to hold on to volume) and an estimated 16% decline in the market for sheet vinyl. One of our key strengths is in refurbishment, but several large flooring contractors have gone out of business which has frustrated the smooth flow of ongoing refurbishment spending. None of this was unexpected and the UK commercial flooring market continues to be challenging.

 

Notwithstanding these problems, we have increased turnover in the UK, partly as a result of increased market share but also as a result of significant growth in sourced product which has crossed over from its target market of "light contract" into the "heavy domestic" marketplace. With the same route to market as commercial flooring, through flooring distributors, we have encouraged this expansion.

 

Rising raw material and energy costs have continued to impact on margins though there are some compensatory effects of which the most significant is improved margins on increased international sales. Our cash balances and even after dividends, acquisitions and plant expenditure it should exceed the levels of last year.

 

Riverside Flooring Ltd, the newest addition to the Group, which was acquired in November 2010, has incurred some significant costs as we tested, adapted and re-commissioned the plant. Previously the plant used to make domestic cushion vinyl.

 

Taking all the above into consideration the Board is confident that the Company will report another year of record profits for the year ended 30 June 2011 in line with market expectations.

 

Enquiries:

 

James Halstead

0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler

020 7796 4133

Michael Sandler

Altium

020 7484 4040

Ben Thorne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQELFLFDFXBBX
Date   Source Headline
9th Apr 20265:32 pmRNSGrant of Options
8th Apr 20265:19 pmRNSHolding(s) in Company
31st Mar 20267:00 amRNSInterim Results
23rd Feb 20264:48 pmRNSPDMR Acquisition of Shares
30th Jan 20263:32 pmRNSShare Buyback - Replacement
30th Jan 20262:44 pmRNSShare Buyback
29th Jan 20267:00 amRNSTrading Update
8th Jan 20268:20 amRNSBlock Listing Six Monthly Return
5th Dec 20251:00 pmRNSResult of AGM
5th Dec 20257:00 amRNSChairman’s Statement to the Annual General Meeting
14th Nov 202512:12 pmRNSDirector/PDMR Shareholding
14th Nov 202512:11 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSPosting of Annual Report and Notice of AGM
1st Oct 20257:00 amRNSPreliminary Results
8th Sep 20257:00 amRNSNotice of Preliminary Results
29th Aug 20253:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSTrading Update
9th Apr 20255:32 pmRNSHolding(s) in Company
7th Apr 202512:25 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSInterim Results
6th Mar 202510:41 amRNSNotice of Interim Results - Replacement
6th Mar 20259:00 amRNSNotice of Inteirm Results
6th Mar 20257:00 amRNSNotice of Interim Results
31st Jan 20257:00 amRNSTrading Update and Notice of Results
27th Jan 20255:09 pmRNSDirector/PDMR Shareholding
6th Jan 20253:15 pmRNSBlock Listing Six Monthly Return
6th Dec 20242:09 pmRNSResults of AGM
6th Dec 20247:00 amRNSAGM Statement
18th Oct 20249:20 amRNSPosting of Annual R&A and Notice of AGM
1st Oct 20247:00 amRNSBoard Changes
1st Oct 20247:00 amRNSPreliminary Results
7th Aug 20248:05 amRNSBlock Listing Six Monthly Return
31st Jul 20247:00 amRNSTrading Update
15th Jul 20247:00 amRNSChange of Broker
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.